Earnings History Data for Corcept Therapeutics Incorporated (CORT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated is a pharmaceutical company. It is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The company focuses on disorders that are associated with a steroid hormone called cortisol. It is developing its lead product, CORLUX for the treatment of the psychotic features of psychotic major depression. Corcept Therapeutics Incorporated is headquartered in Menlo Park, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
05-05-2022 AH 4:05 PM ET
(May 5)
CORT Corcept Therapeutics Incorporated 2,340 0.20 0.23 0.18 Corcept Therapeutics GAAP EPS of $0.20 misses by $0.03, revenue of $93.69M misses by $4.91M
[5/5/2022 4:16 PM]
19.11 -2.20 
(-10.34%)
21.32 0.0 
(0.00%)
15.82 - 25.68 1,716,252 920,000 3,005
15-02-2022 AH 4:05 PM ET
(Feb 15)
CORT Corcept Therapeutics Incorporated 2,310 0.26 0.22 0.20 Corcept Therapeutics Non-GAAP EPS of $0.35 in-line, revenue of $98.8M misses by $1.77M
[2/15/2022 4:12 PM]
22.84 2.53 
(12.46%)
20.35 0.04 
(0.20%)
15.82 - 28.25 1,451,587 760,000 300
03-11-2021 AH 4:05 PM ET
(Nov 3)
CORT Corcept Therapeutics Incorporated 2,110 0.24 0.19 0.17 Corcept Therapeutics EPS beats by $0.09, misses on revenue
[11/3/2021 4:12 PM]
20.07 1.83 
(10.01%)
18.50 0.26 
(1.43%)
16.67 - 31.18 695,565 630,000 214,220
29-07-2021 AH 4:10 PM ET
(Jul 29)
CORT Corcept Therapeutics Incorporated 2,330 0.21 0.14 0.23 Corcept Therapeutics EPS beats by $0.13, beats on revenue
[7/29/2021 4:25 PM]
20.74 0.45 
(2.19%)
20.29 0.0 
(0.00%)
12.20 - 31.18 557,954 550,000 9,638
06-05-2021 AH 4:05 PM ET
(May 6)
CORT Corcept Therapeutics Incorporated 2,590 0.18 0.21 0.25 Corcept Therapeutics EPS beats by $0.01, misses on revenue
[5/6/2021 4:21 PM]
21.12 -0.59 
(-2.72%)
21.18 -0.53 
(-2.44%)
12.20 - 31.18 630,432 460,000 5,443
08-02-2021 AH 4:05 PM ET
(Feb 8)
CORT Corcept Therapeutics Incorporated 3,420 N/A 0.16 0.24 Corcept Therapeutics reports preliminary Q4 results
[2/8/2021 4:13 PM]
29.62 -0.94 
(-3.08%)
29.07 -1.49 
(-4.88%)
9.70 - 31.18 879,311 609,446 4,204
03-11-2020 AH 4:05 PM ET
(Nov 3)
CORT Corcept Therapeutics Incorporated 1,940 0.17 0.21 0.22 Corcept Therapeutics EPS beats by $0.01, misses on revenue
[11/3/2020 4:07 PM]
18.19 0.39 
(2.19%)
16.64 -1.16 
(-6.52%)
9.70 - 23.48 922,429 838,698 956
04-08-2020 AH 4:05 PM ET
(Aug 4)
CORT Corcept Therapeutics Incorporated 1,710 0.23 0.20 0.17 Corcept Therapeutics EPS beats by $0.01, misses on revenue
[8/4/2020 4:12 PM]
14.47 -1.22 
(-7.78%)
13.70 -1.99 
(-12.68%)
9.70 - 18.52 2,560,925 964,912 39,223